검색
Cyclerion Therapeutics Inc
CYCN관심 목록에 추가
3.380USD
-0.010-0.29%
종가 06/30, 16:00（ET）시세는 15분 지연됩니다
12.92M시가총액
손실P/E TTM
자세한 내용은 Cyclerion Therapeutics Inc 회사
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Inc 정보
종목 코드 CYCN
회사 이름Cyclerion Therapeutics Inc
상장일Mar 18, 2019
CEOGraul (Regina M)
직원 수1
유형Ordinary Share
회계 연도 종료Mar 18
주소301 Binney Street
도시CAMBRIDGE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02142
전화16176217722
웹사이트https://www.cyclerion.com/
종목 코드 CYCN
상장일Mar 18, 2019
CEOGraul (Regina M)
Cyclerion Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
자주 묻는 질문
Cyclerion Therapeutics Inc의 상위 5대 주주는 누구인가요?
Cyclerion Therapeutics Inc의 상위 5대 주주는 다음과 같습니다: Dr. Peter M. Hecht, Ph.D.
Cyclerion Therapeutics Inc(CYCN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Cyclerion Therapeutics Inc의 주식을 보유한 기관은 총 37곳이며, 이들이 보유한 주식의 총 가치는 약 318.08K로 전체 발행 주식의 7.35%를 차지합니다. 이는 2025Q4 대비 -667233.00 증가한 수치입니다.